danazol has been researched along with Angiitis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curd, JG; Pizzo, CJ; Prograis, LJ; Yelvington, M | 1 |
| Chiu, HC; Hsiao, GH | 2 |
| Black, MM; Ellis, JP; Wakelin, SH | 1 |
| Bauters, F; Bourgeois, E; Caulier, MT; Dupriez, B; Fenaux, P; Rose, C | 1 |
5 other study(ies) available for danazol and Angiitis
| Article | Year |
|---|---|
Immunodiffusion assay of C1 inhibitor function in serum: prospective analysis in angioedema-urticaria.
Topics: Angioedema; Complement C1 Inactivator Proteins; Danazol; Humans; Immunodiffusion; Prospective Studies; Stanozolol; Urticaria; Vasculitis | 1983 |
Livedoid vasculitis. Response to low-dose danazol.
Topics: Adult; Danazol; Estrogen Antagonists; Female; Humans; Skin Diseases, Vascular; Vasculitis | 1996 |
Low-dose danazol in the treatment of livedoid vasculitis.
Topics: Administration, Oral; Adult; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation; Blood Vessels; Cicatrix; Danazol; Estrogen Antagonists; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Hyperpigmentation; Male; Plasminogen; Protein C; Protein S; Purpura; Remission Induction; Safety; Skin Diseases, Vascular; Skin Ulcer; Telangiectasis; Tissue Plasminogen Activator; Vasculitis; Wound Healing | 1997 |
Livedoid vasculitis with anticardiolipin antibodies: improvement with danazol.
Topics: Adult; Antibodies, Anticardiolipin; Danazol; Estrogen Antagonists; Female; Humans; Leg Dermatoses; Skin Diseases, Vascular; Vasculitis | 1998 |
Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Autoimmune Diseases; Blood Platelets; Cellular Senescence; Cerebral Hemorrhage; Combined Modality Therapy; Danazol; Disease Progression; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Interleukin-3; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Platelet Count; Recurrence; Retrospective Studies; Sjogren's Syndrome; Splenectomy; Thrombocytopenia; Treatment Outcome; Treatment Refusal; Vasculitis | 2001 |